Mannatech Inc (MTEX) shareholders
Close on Nov 16, 2026Market cap $7.26MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Toth Robert | 99,254 | 5.10% | 13D (active) | Jan 2, 2026 |
| Marlin Ray Robbins | 96,362 | 5.10% | 13G (passive) | Jun 14, 2022 |
| Lacore Terry | – | – | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MTEX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 52,163 | 2.70% | $271.77K | – | 0.00% |
| Vanguard Capital Management LLC | 41,528 | 2.15% | $216.36K | −8,089 | 0.00% |
| Renaissance Technologies LLC | 30,078 | 1.56% | $156.71K | −800 | 0.00% |
| IFG Advisory, LLC | 19,090 | 0.99% | $99.46K | New | 0.00% |
| Acadian Asset Management LLC | 4,690 | 0.24% | $24.00K | −3,051 | 0.00% |
| Vanguard Fiduciary Trust Co | 2,679 | 0.14% | $13.96K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 727 | 0.04% | $3.79K | +255 | 0.00% |
| Royal Bank of Canada | 316 | 0.02% | $2.00K | +236 | 0.00% |
| Vanguard Global Advisers, LLC | 250 | 0.01% | $1.30K | – | 0.00% |
| Wells Fargo & Company/Mn | 201 | 0.01% | $1.05K | +200 | 0.00% |
| UBS Group AG | 48 | 0.00% | $250 | −437 | 0.00% |
| National Bank Of Canada /Fi/ | 30 | 0.00% | $150 | – | 0.00% |
| SRS Capital Advisors, Inc. | 12 | 0.00% | $63 | – | 0.00% |
| Morgan Stanley | 2 | 0.00% | $15 | – | 0.00% |
| Citigroup Inc | 1 | 0.00% | $5 | New | 0.00% |
| SBI Securities Co., Ltd. | 1 | 0.00% | $5 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 16 | 0M | 7.9% | 2 / 3 | 4 / 4 | 0M | 0M |
| Q1 2026 | 18 | 0M | 9.6% | 5 / 3 | 5 / 5 | 0M | 0M |
| Q4 2025 | 19 | 0M | 10.8% | 2 / 4 | 7 / 4 | 0M | 0M |
| Q3 2025 | 21 | 0M | 11.5% | 2 / 6 | 5 / 2 | 0M | 0M |
| Q2 2025 | 21 | 0M | 11.3% | 2 / 6 | 3 / 2 | 0M | 0M |
| Q1 2025 | 21 | 0M | 11.3% | 4 / 3 | 4 / 0 | 0M | 0M |
| Q4 2024 | 17 | 0M | 10.3% | 4 / 2 | 4 / 1 | 0M | 0M |
| Q3 2024 | 14 | 0M | 12.0% | 1 / 2 | 4 / 3 | 0M | 0M |
| Q2 2024 | 17 | 0M | 12.5% | 1 / 5 | 5 / 2 | 0M | 0M |
| Q1 2024 | 18 | 0M | 12.5% | 2 / 5 | 3 / 1 | 0M | 0M |
| Q4 2023 | 17 | 0M | 12.5% | 1 / 6 | 4 / 5 | 0M | 0M |
| Q3 2023 | 21 | 0M | 22.7% | 2 / 2 | 5 / 3 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
14 funds held MTEX in Q2 2026, 78% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of MTEX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 31,432 | 1.63% | $163.76K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 7,400 | 0.38% | $38.55K | 0.00% | Jun 30, 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 5,566 | 0.29% | $29.00K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 4,495 | 0.23% | $25.62K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 2,696 | 0.14% | $14.05K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 1,681 | 0.09% | $9.58K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 1,393 | 0.07% | $7.94K | 0.00% | May 31, 2026 |
| U.S. Targeted Value Portfolio | 969 | 0.05% | $4.64K | 0.00% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 422 | 0.02% | $2.41K | 0.00% | May 31, 2026 |
| Dimensional U.S. Targeted Value ETF | 164 | 0.01% | $786 | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Yasir Haider | Chief Financial Officer | – | – | Jun 18, 2026 |
| James Clavijo | Chief Financial Officer | – | – | Aug 28, 2025 |
| Landen Granvel Fredrick | President and CEO | 3,975 | 0.21% | Aug 28, 2025 |
| Erin Kemmler Barta | General Counsel | 3,000 | 0.16% | Aug 28, 2025 |
| Seifrick A. John | Director | 13,746 | 0.71% | Jun 5, 2026 |
| Robert Toth | Director | 95,920 | 4.97% | Jun 5, 2026 |
| Larry A. Jobe | Director | 70,000 | 3.63% | May 21, 2026 |
| Kevin Andrew Robbins | Director | 33,333 | 1.73% | May 20, 2026 |
| J. Stanley Fredrick | Director | 1,611,765 | 83.53% | Jan 6, 2026 |
| Tyler Rameson | Director | 306,673 | 15.89% | Jan 6, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Larry A. Jobe Director | May 20, 2026 | Buy | +2,803 | $4.12 | $11.55K | 70,000 |
| Kevin Andrew Robbins Director | May 19, 2026 | Buy | +7,100 | $4.17 | $29.61K | 33,333 |
| Larry A. Jobe Director | May 19, 2026 | Buy | +5,000 | $4.20 | $21.00K | 67,197 |
| Robert Toth Director | Jan 2, 2026 | Award | +4,790 | $8.35 | $40.00K | 95,920 |
| Tyler Rameson Director | Jan 2, 2026 | Award | +4,790 | $8.35 | $40.00K | 306,673 |
| J. Stanley Fredrick Director | Jan 2, 2026 | Award | +4,790 | $8.35 | $40.00K | 361,765 |
| Larry A. Jobe Director | Jan 2, 2026 | Award | +4,790 | $8.35 | $40.00K | 62,197 |
| Seifrick A. John Director | Jan 2, 2026 | Award | +4,790 | $8.35 | $40.00K | 13,746 |
| Kevin Andrew Robbins Director | Jan 2, 2026 | Award | +4,790 | $8.35 | $40.00K | 26,233 |
| Larry A. Jobe Director | Jan 2, 2025 | Award | +2,686 | $14.89 | $39.99K | 57,407 |
| J. Stanley Fredrick Director | Jan 2, 2025 | Award | +2,686 | $14.89 | $39.99K | 356,975 |
| Robert Toth Director | Jan 2, 2025 | Award | +2,686 | $14.89 | $39.99K | 91,130 |
| Seifrick A. John Director | Jan 2, 2025 | Award | +2,686 | $14.89 | $39.99K | 8,956 |
| Tyler Rameson Director | Jan 2, 2025 | Award | +2,686 | $14.89 | $39.99K | 301,883 |
| Kevin Andrew Robbins Director | Jan 2, 2025 | Award | +2,686 | $14.89 | $39.99K | 21,443 |
| Larry A. Jobe Director | Sep 9, 2024 | Sale | −16,288 | $7.75 | $126.23K | 54,721 |
| Tyler Rameson Director | Sep 9, 2024 | Buy | +16,288 | $7.75 | $126.23K | 299,197 |
| Larry A. Jobe Director | May 22, 2024 | Sale | −1,012 | $7.60 | $7.69K | 71,009 |
| Landen Granvel Fredrick COO/Interim CFO | Mar 11, 2024 | Award | +8,187 | $9.16 | $74.99K | 12,162 |
| J. Stanley Fredrick Director | Jan 2, 2024 | Award | +4,932 | $8.11 | $40.00K | 354,289 |
| Kevin Andrew Robbins Director | Jan 2, 2024 | Award | +4,932 | $8.11 | $40.00K | 18,757 |
| Tyler Rameson Director | Jan 2, 2024 | Award | +4,932 | $8.11 | $40.00K | 282,909 |
| Seifrick A. John Director | Jan 2, 2024 | Award | +4,932 | $8.11 | $40.00K | 6,270 |
| Larry A. Jobe Director | Jan 2, 2024 | Award | +4,932 | $8.11 | $40.00K | 72,021 |
| J. Stanley Fredrick Director | Jan 2, 2024 | Award | +4,932 | $8.11 | $40.00K | 229,289 |
| Alfredo Bala CEO and President | Aug 30, 2023 | Sale | −1,000 | $12.40 | $12.40K | 3,137 |
| Larry A. Jobe Director | Aug 18, 2023 | Sale | −1,217 | $12.82 | $15.60K | 67,089 |
| Alfredo Bala CEO and President | Jun 30, 2023 | Sale | −115 | $12.62 | $1.45K | 4,137 |
| Alfredo Bala CEO and President | Jun 29, 2023 | Sale | −154 | $12.89 | $1.99K | 4,252 |
| Landen Granvel Fredrick Chief Sales/Marketing Officer | Feb 14, 2023 | Option exercise | +2,000 | $5.72 | $11.44K | 3,975 |
| J. Stanley Fredrick Director | Jan 3, 2023 | Award | +2,294 | $17.43 | $39.98K | 224,357 |
| Larry A. Jobe Director | Jan 3, 2023 | Award | +2,294 | $17.43 | $39.98K | 68,306 |
| Seifrick A. John Director | Jan 3, 2023 | Award | +1,338 | $17.43 | $23.32K | 1,338 |
| Robert Toth Director | Jan 3, 2023 | Award | +2,294 | $17.43 | $39.98K | 88,444 |
| Kevin Andrew Robbins Director | Jan 3, 2023 | Award | +2,294 | $17.43 | $39.98K | 13,825 |
| Tyler Rameson Director | Jan 3, 2023 | Award | +2,294 | $17.43 | $39.98K | 277,977 |
| Alfredo Bala CEO and President | Dec 21, 2022 | Sale | −3,500 | $19.69 | $68.92K | 4,406 |
| Kevin Andrew Robbins Director | Dec 8, 2022 | Sale | −1,500 | $22.00 | $33.00K | 11,531 |
| Kevin Andrew Robbins Director | Mar 28, 2022 | Sale | −1,100 | $36.57 | $40.23K | 13,031 |
| J. Stanley Fredrick Director | Jan 3, 2022 | Award | +1,012 | $39.49 | $39.96K | 222,063 |
| Tyler Rameson Director | Jan 3, 2022 | Award | +1,012 | $39.49 | $39.96K | 275,683 |
| Larry A. Jobe Director | Jan 3, 2022 | Award | +1,012 | $39.49 | $39.96K | 66,012 |
| Kevin Andrew Robbins Director | Jan 3, 2022 | Award | +1,012 | $39.49 | $39.96K | 14,131 |
| Eric W. Schrier Director | Jan 3, 2022 | Award | +1,012 | $39.49 | $39.96K | 19,118 |
| Robert Toth Director | Jan 3, 2022 | Award | +1,012 | $39.49 | $39.96K | 86,150 |
| Alfredo Bala CEO and President | Nov 30, 2021 | Tax withholding | −2,724 | $35.97 | $97.98K | 7,906 |
| Alfredo Bala CEO and President | Nov 30, 2021 | Option exercise | +5,000 | $19.60 | $98.00K | 10,630 |
| Erin Kemmler Barta General Counsel | Nov 29, 2021 | Option exercise | +3,000 | $5.72 | $17.16K | 3,000 |
| Alfredo Bala CEO and President | Nov 29, 2021 | Option exercise | +1,150 | $15.70 | $18.06K | 5,630 |
| David Allen Johnson Chief Financial Officer | Nov 23, 2021 | Option exercise | +12,500 | $15.70 | $196.25K | 12,500 |
| Ronald Dale Norman Sr VP Treasury | Sep 7, 2021 | Option exercise | +5,000 | $5.72 | $28.60K | 6,030 |
| Robert Toth Director | Sep 1, 2021 | Option exercise | +3,333 | $16.93 | $56.43K | 85,138 |
| Robert Toth Director | Sep 1, 2021 | Option exercise | +5,000 | $19.60 | $98.00K | 81,805 |
| Eric W. Schrier Director | Aug 30, 2021 | Tax withholding | −5,218 | $33.89 | $176.84K | 18,106 |
| Eric W. Schrier Director | Aug 30, 2021 | Option exercise | +5,000 | $21.18 | $105.90K | 23,324 |
| Eric W. Schrier Director | Aug 30, 2021 | Option exercise | +5,000 | $14.19 | $70.95K | 18,324 |
| Kevin Andrew Robbins Director | Aug 26, 2021 | Option exercise | +5,000 | $17.28 | $86.40K | 13,119 |
| J. Stanley Fredrick Director | Aug 24, 2021 | Option exercise | +5,000 | $5.72 | $28.60K | 221,051 |
| Kevin Andrew Robbins Director | Aug 23, 2021 | Sale | −1,500 | $32.99 | $49.49K | 8,119 |
| Kevin Andrew Robbins Director | Aug 20, 2021 | Sale | −1,000 | $32.24 | $32.24K | 9,619 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Mannatech's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Alfredo Bala Officer | Sep 27, 2024 | 1,607 | $12.21K | Sep 27, 2024 | Incentive Stock Option |
| Alfredo Bala Officer | Jul 19, 2024 | 1,500 | $21.75K | Jul 19, 2024 | Incentive Stock Option |
| Alfredo Bala Officer | Aug 29, 2023 | 1,000 | $22.34M | Aug 29, 2023 | Incentive Stock Option |
| Alfredo Bala Officer | Jun 29, 2023 | 1,000 | $12.80K | Jun 29, 2023 | Incentive Stock Option |
See a number that looks wrong?